Abstract
Human cytomegalovirus (CMV) infection is usually self-limiting in healthy adults, but it can lead to significant complications. This report presents the case of an immunocompetent adult with fulminant hepatitis caused by a CMV infection requiring emergency living-donor liver transplantation. A 39-year-old female with persistent fever for 6 weeks was referred for fulminant hepatitis, but the underlying etiology was not identified. Rapid deterioration of consciousness led to an emergency living-donor liver transplant using a modified right lobe graft. She showed increasing CMV antigenemia after surgery and the explant liver pathology showed massive hepatic necrosis with positive staining for CMV protein. Treatment with ganciclovir improved the graft liver function and her general condition recovered. This report presents a rare case of CMV-associated fulminant hepatitis which led to emergency liver transplantation. Although CMV is rare, it should be included in the differential diagnosis of patients with severe hepatitis, even immunocompetent patients, after other more common etiologies have been excluded.
Similar content being viewed by others
Abbreviations
- CMV:
-
Cytomegalovirus
- FHF:
-
Fulminant hepatic failure
References
Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis. 1997;24:52–6.
Gueddi S, Righini M, Mezger N, Morard I, Kaiser L, Giostra E, et al. Portal vein thrombosis following a primary cytomegalovirus infection in an immunocompetent adult. Thromb Haemost. 2006;95:199–201.
Klemola E, Kaariainen L. Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br Med J. 1965;2:1099–102.
Serna-Higuera C, Gonzalez-Garcia M, Milicua JM, Munoz V. Acute cholestatic hepatitis by cytomegalovirus in an immunocompetent patient resolved with ganciclovir. J Clin Gastroenterol. 1999;29:276–7.
Patel R, Paya C. Cytomegalovirus infection and disease in solid organ transplant recipients. In: Bowden RA, Ljungman P, Paya CV, editors. Transplant infections. Philadelphia: Lippincott-Raven Publishers; 1998. p. 229–44.
Kanj SS, Sharara AI, Clavien PA, Hamilton JD. Cytomegalovirus infection following liver transplantation: review of the literature. Clin Infect Dis. 1996;22:537–49.
Seehofer D, Rayes N, Tullius SG, Schmidt CA, Neumann UP, Radke C, et al. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up. Liver Transpl. 2002;8:1138–46.
Limaye AP, Bakthavatsalam R, Kim HW, Kuhr CS, Halldorson JB, Healey PJ, et al. Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis. Transplantation. 2004;78:1390–6.
Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2004;4:611–20.
Singh N, Wannstedt C, Keyes L, Gayowski T, Wagener MM, Cacciarelli TV. Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease. Transplantation. 2005;79:85–90.
Lamb SG, Stern H. Cytomegalovirus mononucleosis with jaundice as presenting sign. Lancet. 1966;2:1003–6.
Cohen JI, Corey GR. Cytomegalovirus infection in the normal host. Medicine (Baltimore). 1985;64:100–14.
Bonnet F, Neau D, Viallard JF, Morlat P, Ragnaud JM, Dupon M, et al. Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adults. Ann Med Interne (Paris). 2001;152:227–35.
Fernandez-Ruiz M, Munoz-Codoceo C, Lopez-Medrano F, Fare-Garcia R, Carbonell-Porras A, Garfia-Castillo C, et al. Cytomegalovirus myopericarditis and hepatitis in an immunocompetent adult: successful treatment with oral valganciclovir. Intern Med. 2008;47:1963–6.
Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med. 2007;120(911):e1–8.
Kano Y, Shiohara T. Current understanding of cytomegalovirus infection in immunocompetent individuals. J Dermatol Sci. 2000;22:196–204.
Räsänen V, Saikku P. Cytomegalovirus hepatitis. Lancet. 1972;2:772.
Zubiaurre L, Zapata E, Bujanda L, Castillo M, Oyarzabal I, Gutierrez-Stampa MA, et al. Cytomegalovirus hepatitis and myopericarditis. World J Gastroenterol. 2007;13:647–8.
Shusterman NH, Frauenhoffer C, Kinsey MD. Fatal massive hepatic necrosis in cytomegalovirus mononucleosis. Ann Intern Med. 1978;88:810–2.
Mason A, Sallie R, Perrilo R, Rayner A, Xu L, Dohner D, et al. Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure. Hepatology. 1996;24:1361–5.
Paya CV, Wiesner RH, Hermans PE, Larson KJ, Ilstrup DM, Krom RA, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time dependent analysis. J Hepatol. 1993;18:185–95.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, YD., Park, GC., Park, PJ. et al. Cytomegalovirus infection-associated fulminant hepatitis in an immunocompetent adult requiring emergency living-donor liver transplantation: report of a case. Surg Today 43, 424–428 (2013). https://doi.org/10.1007/s00595-012-0209-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-012-0209-6